Market Overview
Cervical dystonia, also known as spasmodic torticollis, is a neurological movement disorder characterized by involuntary contractions of neck muscles. These contractions cause abnormal postures and twisting of the neck. Cervical dystonia can affect men and women of any age, but symptoms typically start between ages 30 to 60. Some common manifestations include abnormal bending or twisting of the neck, protrusion of the chin, or turning of the head to one side.
Treatment options include botulinum toxin injections, physical therapy, oral medications, and surgical interventions like deep brain stimulation. The global Cervical Dystonia Market is primarily driven by the rising geriatric population who are at a higher risk of developing the condition, along with growing awareness regarding the disease.
The cervical dystonia market is estimated to be valued at USD 265.1 Mn in 2024 and is expected to reach USD 400.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031.
Key Takeaways
Key Players: Key players operating in the cervical dystonia market are Merz Pharma GmbH & Co. KGaA, Ipsen Pharma, US WorldMeds, LLC., Allergan, Revance Therapeutics, Inc., and Eisai Co. Ltd.
Key Opportunities: Increasing research into novel drug development for cervical dystonia offers immense opportunities for market players. In addition, untapped emerging markets in Asia Pacific and Latin America are lucrative avenues for expanding business operations. Global Expansion: Major players are actively pursuing global expansion strategies through collaborations, partnerships, and acquisitions to strengthen their distribution networks across international territories. For instance, Merz Pharma markets its Xeomin product for cervical dystonia in over 90 countries worldwide.
Market Drivers: One of the key drivers for the cervical dystonia market is the rising geriatric population globally. Elderly are more prone to develop dystonia due to age-related neurological changes. In addition, increasing awareness about dystonia therapies through patient support organizations and social media also drives market growth.
Market Restraints: High treatment costs associated with medication and deep brain stimulation devices pose a major challenge for widespread adoption. In addition, lack of approved therapies for children with cervical dystonia limits market potential.
Segment Analysis The cervical dystonia market is dominated by botulinum toxin segment. Botulinum toxin injections are the first line treatment option for cervical dystonia due to its high effectiveness in reducing muscle contractions and controlling neck pain and stiffness. It is minimally invasive and provides relief in over 60% of patients receiving injections. Within botulinum toxin segment, botulinum toxin type A dominated the market due to U.S. FDA approval and established efficacy and safety profile of drugs like Botox, Dysport and Xeomin. The oral drug segment is expected to grow at a considerable pace during the forecast period with drugs in the pipeline promising better efficacy and longer duration of action.
Global Analysis North America currently dominates the cervical dystonia market and is expected to continue its dominance during the forecast period. High awareness levels regarding available treatment options, favorable reimbursement policies, and presence of key players driving regional market growth. Asia Pacific region is poised to grow at fastest pace attributed to growing geriatric population, increasing disease prevalence and growing disposable incomes allowing access to available treatments. Factors such as improving healthcare infrastructure, expanding patient pool and increasing collaborations between regional and international market players are contributing to market growth in emerging economies in regions like Latin America and Middle East and Africa.
Get this Report in Japanese Language: 頸部ジストニア市場
Get this Report in Korean Language: 경부 디스토니아 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
